NO840869L - Anvendelse av pyrazolonderivater som lipoksygengasshemmer, ved terapi av ischemier og hjerterytmeforstyrrelser, hud- og oeyenbetennelser, samt av reumatiske, allergiske og asmatiske sykdommer, oedemer, lungeembolier, pulmolar, osv - Google Patents

Anvendelse av pyrazolonderivater som lipoksygengasshemmer, ved terapi av ischemier og hjerterytmeforstyrrelser, hud- og oeyenbetennelser, samt av reumatiske, allergiske og asmatiske sykdommer, oedemer, lungeembolier, pulmolar, osv

Info

Publication number
NO840869L
NO840869L NO840869A NO840869A NO840869L NO 840869 L NO840869 L NO 840869L NO 840869 A NO840869 A NO 840869A NO 840869 A NO840869 A NO 840869A NO 840869 L NO840869 L NO 840869L
Authority
NO
Norway
Prior art keywords
residue
atoms
stands
formula
allergic
Prior art date
Application number
NO840869A
Other languages
English (en)
Norwegian (no)
Inventor
Mithat Mardin
Friedel Seuter
Elisabeth Perzborn
Klaus Schlossmann
Dieter Mayer
Volker Fiedler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19833308881 external-priority patent/DE3308881A1/de
Priority claimed from DE19833342628 external-priority patent/DE3342628A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO840869L publication Critical patent/NO840869L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO840869A 1983-03-12 1984-03-07 Anvendelse av pyrazolonderivater som lipoksygengasshemmer, ved terapi av ischemier og hjerterytmeforstyrrelser, hud- og oeyenbetennelser, samt av reumatiske, allergiske og asmatiske sykdommer, oedemer, lungeembolier, pulmolar, osv NO840869L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833308881 DE3308881A1 (de) 1983-03-12 1983-03-12 Verwendung von pyrazolonderivaten als lipoxygenasehemmer, bei der therapie von ischaemien und herzrhythmusstoerungen sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung
DE19833342628 DE3342628A1 (de) 1983-11-25 1983-11-25 Verwendung von pyrazolonderivaten als lipoxygenasehemmer bei der therapie von ischaemien und herzrhythmusstoerungen, haut- und augenentzuendungen, sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, schocklunge, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
NO840869L true NO840869L (no) 1984-09-13

Family

ID=25808986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840869A NO840869L (no) 1983-03-12 1984-03-07 Anvendelse av pyrazolonderivater som lipoksygengasshemmer, ved terapi av ischemier og hjerterytmeforstyrrelser, hud- og oeyenbetennelser, samt av reumatiske, allergiske og asmatiske sykdommer, oedemer, lungeembolier, pulmolar, osv

Country Status (10)

Country Link
US (1) US4670460A (en])
EP (1) EP0125406A2 (en])
DK (1) DK143684A (en])
ES (1) ES8503945A1 (en])
FI (1) FI840954L (en])
GR (1) GR81867B (en])
HU (1) HUT34123A (en])
IL (1) IL71202A0 (en])
NO (1) NO840869L (en])
PT (1) PT78239B (en])

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35801E (en) * 1985-05-20 1998-05-19 Mitsubishi Chemical Corporation Prophylactic and therapeutic composition for circulatory disorders and method of treatment
DK169672B1 (da) * 1985-05-20 1995-01-09 Mitsubishi Chem Ind Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
JPH0737990B2 (ja) * 1990-10-12 1995-04-26 寳酒造株式会社 糖類の標識方法及び糖類標識用キット
US5183825A (en) * 1992-04-07 1993-02-02 American Home Products Corporation 4-arylmethyl-5-alkyl-3H-pyrazol-3-ones and hypoglycemic use
JPH0725765A (ja) * 1993-07-07 1995-01-27 Mitsubishi Chem Corp 眼疾患用薬剤
GB0011095D0 (en) * 2000-05-08 2000-06-28 Black James Foundation astrin and cholecystokinin receptor ligands (III)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147276A (en) * 1964-09-01 Pyrazolones
DE2427272C3 (de) * 1974-06-06 1981-10-01 Bayer Ag, 5090 Leverkusen 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2526467A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1151164A (en) * 1978-01-13 1983-08-02 Atsuyuki Kojima Conjugated ketone compounds and their production and use
DE3176313D1 (en) * 1980-12-09 1987-08-20 Teijin Ltd Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof
JPS5846079A (ja) * 1981-09-12 1983-03-17 Santen Pharmaceut Co Ltd ベンゾチアゾリン環を有するエ−テル類
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles

Also Published As

Publication number Publication date
DK143684A (da) 1984-09-13
PT78239A (en) 1984-04-01
PT78239B (en) 1986-04-24
FI840954A7 (fi) 1984-09-13
IL71202A0 (en) 1984-06-29
HUT34123A (en) 1985-02-28
ES530432A0 (es) 1985-04-16
ES8503945A1 (es) 1985-04-16
FI840954L (fi) 1984-09-13
GR81867B (en]) 1984-12-12
US4670460A (en) 1987-06-02
DK143684D0 (da) 1984-02-29
FI840954A0 (fi) 1984-03-08
EP0125406A2 (de) 1984-11-21

Similar Documents

Publication Publication Date Title
US4800211A (en) 5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors
KR101952457B1 (ko) [3-(1-(1h-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올의 에스테르 프로드러그
JP3071820B2 (ja) アナフィラキシーの遅反応性物質に対する拮抗薬としてのリポキシンａ▲下４▼およびその誘導体の使用
RO113643B1 (ro) Derivat de acizi imidazolalchenici si procedeu de preparare a acestuia
NO840869L (no) Anvendelse av pyrazolonderivater som lipoksygengasshemmer, ved terapi av ischemier og hjerterytmeforstyrrelser, hud- og oeyenbetennelser, samt av reumatiske, allergiske og asmatiske sykdommer, oedemer, lungeembolier, pulmolar, osv
KR100661774B1 (ko) 광학적 활성 피리딜-4에이치-1,2,4-옥사디아진 유도체 및이것의 혈관 질환의 치료에서의 용도
US5041444A (en) Benzoxepin derivatives
US4661484A (en) Pyridazinone derivatives and salts thereof as cardiac stimulants
JP3964417B2 (ja) インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
JPH072793A (ja) 複素環式化合物
US4659732A (en) Lipoxygenase inhibiting 1-arylalkyl-, 1-arylthio-, and 1-aryloxypyrazole-4,5-diones
EP0144845A1 (en) Indolylacetic acid derivatives and preparations containing same for medical treatments
US4540707A (en) Nafazatrom as a lipoxygenase inhibitor
JPS59175469A (ja) ピラゾロン誘導体のリポキシゲナ−ゼ禁止剤としての使用
JPH05506440A (ja) アルコキシ置換ジヒドロベンゾピラン―２―カルボン酸およびその誘導体
Bitterman et al. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock
JPS6287586A (ja) 強心性ヘテロサイクロカルボニル−及びアセチル−チアゾロン類
JP4223237B2 (ja) ３−フェニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、これを含有する医薬品、その使用及びその製法
EP0174458A1 (de) Verwendung von 4H-1,4 Benzothiazinen bei der Prophylaxe und Therapie von Erkrankungen der Atemwege, Entzündungen/Rheuma, thromboembolischen Erkrankungen, Ischämien und Infarkten, Herzrhythmusstörungen, Arteriosklerose und Dermatosen, Arzneimittel zu diesem Zweck sowie Wirkstoffe, die in diesen Arnzeimitteln enthalten sind
JP2677382B2 (ja) ロイコトリエン拮抗剤
JP2007530566A (ja) （ｒ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
DE3342628A1 (de) Verwendung von pyrazolonderivaten als lipoxygenasehemmer bei der therapie von ischaemien und herzrhythmusstoerungen, haut- und augenentzuendungen, sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, schocklunge, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung
JPH0586389B2 (en])
KR19990077341A (ko) 신규 피리딘카르복사미드 유도체
JPS59225187A (ja) テトラヒドロ−β−カルボリン誘導体及びその製法